Jeffrey Blizard - 04 Jun 2024 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role: Director
Signature: /s/ Megan Smeykal, Attorney-in-fact
Issuer symbol: TELA
Transactions as of: 04 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2024, 16:55:53 UTC
Previous filing: 18 Mar 2025
Next filing: 18 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TELA	Common Stock	Award	$0	+6,375		$0.000000	6,375	04 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TELA	Stock Option (Right to Buy)	Award	$0	+9,300		$0.000000	9,300	04 Jun 2024	Common Stock	9,300	$5.71	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units will vest in three equal annual installments beginning on June 4, 2025, in each case subject to the Reporting Person's continued service through the applicable vesting date.
F2	The option vests in 36 equal monthly installments on each monthly anniversary of June 4, 2024, in each case subject to the Reporting Person's continued service through the applicable vesting date.